Opioids Cough Syrups Cough Syrup Anabolic Steroids Psychotropic Drugs Steroids Prescription Drugs Fentanyl Tramadol Drug Regulation Codeine Tirzepatide Drug Abuse Kratom Unauthorized Medications Anesthetic Drugs Medication Regulation Synthetic Opioids Clembuterol Opioid Crisis Medication Safety Drug Management Pain Management Prescription Medications Anesthesia Narcotics Drug Theft Codeine-based Medicines Drug Effects Benzodiazepines OTC Drug Restrictions Medication Regulations Mephentermine Sulphate Xanax Oxycodon Gabapentin Regulations Medication Misuse Drug Regulations Mifepristone Performance Enhancers Habit-forming Medicines Opiates Medical Cannabis Fentanyl Regulation Barbiturates Potency Medications Medication Injectable Drugs Psychotropic Medications Habit-Forming Drugs Hydrocodone Codeine Phosphate
Want to see what podcasts are saying about this topic? Search across 135K+ podcasts. Explore Radar
The agency says the move will target concentrated and lab‑made 7‑hydroxymitragynine products because regulators link them to rising poisonings and local overdose deaths.
